RELATIONSHIP OF SERUM INSULIN WITH SERUM TESTOSTERONE LEVELS IN NON-OBESE AND OBESE DIABETIC MALES
DOI:
https://doi.org/10.69656/pjp.v20i4.1697Keywords:
obesity, testosterone, insulin, diabetes mellitus, diabetes mellitus type II, diabetic males, obese diabetic males, waist circumference, body mass index, waist hip ratioAbstract
Background: Obesity and diabetes whenever merge within males, brew hyperinsulinemia that accentuates their diabetic status by withdrawing crucial benefits of testosterone from over their glycaemic homeostasis. This study aimed to access and compare testosterone and insulin levels among diabetic males. Methods: It was a cross-sectional study, devised on comparative and correlational grounds, conducted in 2023 at medical OPDs associated with Multan Medical and Dental College, and Nishtar Medical University, Multan. Diabetic males aged 30?40 years were divided into non-obese diabetic males (NODMs, Group A) and obese diabetic male (ODMs, Group B) with 67 individuals falling into each group. Serum testosterone and serum insulin levels of the subjects were measured via ELISA. Results: Serum testosterone levels (ng/dL) of NODMs [455.0, 310–920] were significantly higher (p=0.00) than those of ODMs [241, 150–380]. Conversely, Serum insulin levels (pmol/L) of ODMs (243.1±25) were significantly higher (p=0.00) than their non-obese diabetic counterparts (133.2±22.7). Also, serum insulin levels had an inverse correlation with serum testosterone levels in both NODMs [(rho=-0.45, p=0.00)] and ODMs [(rho=-0.52, p=0.00)]. Serum testosterone levels showed a negative correlation with BMI and WHR while serum insulin levels showed a positive correlation with them in NODMs [{(rho=-0.23, p=0.05), (rho=-0.28, p=0.02)}, {(rho=-0.27, p=0.02), (rho=-0.24, p=0.04)}] and ODMs [{(rho=0.29, p=0.01), (rho=0.40, p=0.00)}, {(rho=0.21, p=0.08), (rho=0.27, p=0.02)}]. Conclusion: ODMs, in contrast to NODMs of South Asian origin, harbour a significant degree of hyperinsulinemia which in turn suppresses their serum testosterone levels.
Pak J Physiol 2024;20(4):17-20, DOI: https://doi.org/10.69656/pjp.v20i4.1697
Downloads
References
Vera-Ponce VJ, Zuzunaga-Montoya FE, Loayza-Castro JA, Vasquez-Romero LE, Paucar CR, Valladares-Garrido MJ, et al. Concordance and associated factors in diagnostic criteria for prediabetes and diabetes: An analysis of fasting glucose, postprandial glucose, and glycated hemoglobin. J Endocrinol Metab 2024;14(1):48–58.
Daryabor G, Atashzar MR, Kabelitz D, Meri S, Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol 2020;11:1582.
Basit A, Fawwad A, Qureshi H, Shera AS; NDSP Members. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ Open 2018;8(8):e020961.
Wittert G, Grossmann M. Obesity, type 2 diabetes, and testosterone in ageing men. Rev Endocr Metab Disord 2022;23(6):1233–42.
Dinakaran A, Ar S, Rajagambeeram R, Nanda SK, Daniel M. SHBG and insulin resistance-nexus revisited. Bioinformation 2024;20(8):816–21.
Ma H, Sun J, Wu X, Mao J, Han Q. Percent body fat was negatively correlated with Testosterone levels in male. PLoS One 2024;19(1):e0294567.
Ellidag HY, Aslankoç R, Kök M, Aykal G, Ayd?n Ö, Özmen Ö, et al. Serum testosterone levels and oxidative stress in type 1 diabetes, type 2 diabetes, and obesity. Endokrynol Pol 2024;75(2):183–91.
Genchi VA, Rossi E, Lauriola C, D’Oria R, Palma G, Borrelli A, et al. Adipose tissue dysfunction and obesity-related male hypogonadism. Int J Mol Sci 2022;23(15):8194.
Uddandrao VVS, Brahma Naidu P, Chandrasekaran P, Saravanan G. Pathophysiology of obesity-related infertility and its prevention and treatment by potential phytotherapeutics. Int J Obes (Lond) 2024;48(2):147–65.
Grossmann M, Wierman ME, Angus P, Handelsman DJ. reproductive endocrinology of nonalcoholic fatty liver disease. Endocr Rev 2019;40(2):417–46.
Tishova Y, Kalinchenko S, Mskhalaya G, Hackett G, Livingston M, König C, et al. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase. Diabetes Obes Metab 2024;26(6):2147–57.
Ramachandran S, Hackett GI, Strange RC. Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups. Andrology 2020;8(5):1222–32.
Dhindsa S, Miller MG, McWhirter CL, Mager DE, Ghanim H, Chaudhuri A, Dandona P. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care 2010;33(6):1186–92.
Behl S, Misra A. Management of obesity in adult Asian Indians. Indian Heart J 2017;69(4):539–44.
Zhu A, Andino J, Daignault-Newton S, Chopra Z, Sarma A, Dupree JM. What is a normal testosterone level for young men? Rethinking the 300 ng/dL cut-off for testosterone deficiency in men 20-44 years old. J Urol 2022;208(6):1295–302.
Peppa ?, Manta A. Sexual dysfunction in diabetic patients: the role of advanced glycation end products. Curr Diabetes Rev 2024;20(2):e070423215531.
Olaogun I, Farag M, Hamid P. The pathophysiology of type 2 diabetes mellitus in non-obese individuals: an overview of the current understanding. Cureus 2020;12(4):e7614.
van Vliet S, Koh HE, Patterson BW, Yoshino M, LaForest R, Gropler RJ, et al. Obesity is associated with increased basal and postprandial ?-cell insulin secretion even in the absence of insulin resistance. Diabetes 2020;69(10):2112–9.
Gianatti EJ, Grossmann M. Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment. Diabet Med 2020;37(2):174–86.
Van de Velde F, Deventer K, Van Gansbeke W, Van Eenoo P, Van Renterghem P, Fiers T, et al. Metabolism of testosterone during weight loss in men with obesity. J Steroid Biochem Mol Biol 2021;209:105851.
Shah SS, Kanani EAM, Kharat SK, Shah PS, Shah RM. Evaluation of the incidence of low testosterone levels in young male adults with moderate to severe obesity-single-centre study from India. Obes Surg 2024;34(3):836–40.
Ken-Dror G, Ajami I, Han TS, Aurelius T, Maheshwari A, Hail HA, et al. Diabetes mellitus and obesity among South Asians with ischemic stroke across three countries. Int J Stroke 2024;19(2):235–43.
Muniyappa R, Narayanappa SBK. Disentangling dual threats: premature coronary artery disease and early-onset type 2 diabetes mellitus in South Asians. J Endocr Soc 2023;8(1):bvad167.
Gucenmez S, Yildiz P, Donderici O, Serter R. The effect of testosterone level on metabolic syndrome: a cross-sectional study. Hormones (Athens) 2024;23(1):163–9.
Christakoudi S, Tsilidis KK, Evangelou E, Riboli E. Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort. Cancer Med 2024;13(3):e6918.
Xin Y, Wise JY, Rajesh M, Cai L. Editorial: Cardiovascular diseases related to diabetes and obesity, volume III. Front Endocrinol (Lausanne) 2024;15:1381446.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
The author(s) retain the Copyrights and allow their publication in Pakistan Journal of Physiology, Pak J Physiol, PJP to be FREE for research and academic purposes. It can be downloaded and stored, printed, presented, projected, cited and quoted with full reference of, and acknowledgement to the author(s) and the PJP. The contents are published with an international CC-BY-ND-4.0 License.
